Brendel Financial Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,694
Closed -$2.09M 103
2025
Q1
$2.09M Sell
20,694
-2,121
-9% -$214K 1.27% 37
2024
Q4
$2.04M Buy
+22,815
New +$2.01M 1.23% 39

Other funds holding BSX

Brendel Financial Advisors's BSX Position: Q2 2025 in Review

Brendel Financial Advisors sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 20,694 shares — an estimated $2.09M sold.

Brendel Financial Advisors first reported a position in BSX in Q4 2024 and held it in 2 quarters. The position peaked at $2.09M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Brendel Financial Advisors reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • Brendel Financial Advisors sold 20,694 Boston Scientific shares in Q2 2025, an estimated $2.09M.
  • Brendel Financial Advisors first reported a position in Boston Scientific in Q4 2024 and held it in 2 quarters.
  • Brendel Financial Advisors's Boston Scientific position peaked at $2.09M in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Brendel Financial Advisors's 13F filing for Q2 2025, filed 11 Jul 2025.